{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:26:28Z","timestamp":1779341188433,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00535-022-01887-3","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:02:51Z","timestamp":1658142171000},"page":"676-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection"],"prefix":"10.1007","volume":"57","author":[{"given":"Kenichiro","family":"Kodama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Johira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shirane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Amioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Naruto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwa","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Uchikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-2156","authenticated-orcid":false,"given":"Hiroshi","family":"Aikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"1887_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"1887_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"1887_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","volume":"57","author":"WC Palmer","year":"2012","unstructured":"Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57:69\u201376.","journal-title":"J Hepatol"},{"key":"1887_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","volume":"118","author":"JL Petrick","year":"2018","unstructured":"Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project. Br J Cancer. 2018;118:1005\u201312.","journal-title":"Br J Cancer"},{"key":"1887_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","volume":"17","author":"N Wongjarupong","year":"2017","unstructured":"Wongjarupong N, Assavapongpaiboon B, Susantitaphong P, et al. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2017;17:149.","journal-title":"BMC Gastroenterol"},{"key":"1887_CR6","first-page":"605","volume":"19","author":"S Kamsa-ard","year":"2018","unstructured":"Kamsa-ard S, Kamsa-ard S, Luvira V, et al. Risk factors for cholangiocarcinoma in Thailand: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2018;19:605\u201314.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1887_CR7","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/hep.29730","volume":"67","author":"AH Ali","year":"2018","unstructured":"Ali AH, Tabibian JH, Nasser-Ghodsi N, et al. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2018;67:2338\u201351.","journal-title":"Hepatology"},{"key":"1887_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186643","volume":"12","author":"JL Petrick","year":"2017","unstructured":"Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based study in SEER-Medicare. PLoS ONE. 2017;12: e0186643.","journal-title":"PLoS ONE"},{"key":"1887_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","volume":"128","author":"YH Shaib","year":"2005","unstructured":"Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005;128:620\u20136.","journal-title":"Gastroenterology"},{"key":"1887_CR10","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.3390\/ijms21218323","volume":"21","author":"S Patergnani","year":"2020","unstructured":"Patergnani S, Danese A, Bouhamida E, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21:8323.","journal-title":"Int J Mol Sci"},{"key":"1887_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","volume":"7","author":"C Cui","year":"2017","unstructured":"Cui C, Merritt R, Fu L, et al. Targeting calcium signaling in cancer therapy. Acta Pharm Sin B. 2017;7:3\u201317.","journal-title":"Acta Pharm Sin B"},{"key":"1887_CR12","first-page":"1090","volume":"55","author":"M Shaughnessy","year":"2019","unstructured":"Shaughnessy M, Lamuraglia G, Klebanov N, et al. Selective uveal melanoma inhibition with calcium channel blockade. Int J Oncol. 2019;55:1090\u20136.","journal-title":"Int J Oncol"},{"key":"1887_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2009.11.014","volume":"86","author":"J Yoshida","year":"2010","unstructured":"Yoshida J, Ishibashi T, Yang M, et al. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells. Life Sci. 2010;86:124\u201332.","journal-title":"Life Sci"},{"key":"1887_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41388-018-0425-7","volume":"38","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wei Y, Zhang L, et al. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP\/TAZ. Oncogene. 2019;38:120\u201339.","journal-title":"Oncogene"},{"key":"1887_CR15","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Delgado G, Felix R. Emerging Role of CaV1.2 Channels in Proliferation and Migration in Distinct Cancer Cell Lines. Oncology. 2017;93:1\u201310.","DOI":"10.1159\/000464293"},{"key":"1887_CR16","doi-asserted-by":"publisher","first-page":"13297","DOI":"10.1038\/ncomms13297","volume":"7","author":"G Jacquemet","year":"2016","unstructured":"Jacquemet G, Baghirov H, Georgiadou M, et al. L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nat Commun. 2016;7:13297.","journal-title":"Nat Commun"},{"key":"1887_CR17","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.3390\/ijms20246112","volume":"20","author":"AR Lee","year":"2019","unstructured":"Lee AR, Seo MJ, Kim J, et al. Lercanidipine synergistically enhances bortezomib cytotoxicity in cancer cells via enhanced endoplasmic reticulum stress and mitochondrial Ca2+ overload. Int J Mol Sci. 2019;20:6112.","journal-title":"Int J Mol Sci"},{"key":"1887_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/CIRCRESAHA.109.200311","volume":"105","author":"R Das","year":"2009","unstructured":"Das R, Burke T, Van Wagoner DR, et al. L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circ Res. 2009;105:167\u201375.","journal-title":"Circ Res"},{"key":"1887_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0022034515571265","volume":"94","author":"PC Trackman","year":"2015","unstructured":"Trackman PC, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res. 2015;94:540\u20136.","journal-title":"J Dent Res"},{"key":"1887_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/CAD.0000000000000947","volume":"31","author":"SJ Tingle","year":"2020","unstructured":"Tingle SJ, Severs GR, Moir JAG, et al. Calcium channel blockers in pancreatic cancer: increased overall survival in a retrospective cohort study. Anticancer Drugs. 2020;31:737\u201341.","journal-title":"Anticancer Drugs"},{"key":"1887_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4291\/wjgp.v6.i4.235","volume":"6","author":"SJ Tingle","year":"2015","unstructured":"Tingle SJ, Moir JA, White SA. Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. World J Gastrointest Pathophysiol. 2015;6:235\u201342.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1887_CR22","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/ijc.33379","volume":"148","author":"B Li","year":"2021","unstructured":"Li B, Cheung KS, Wong IY, et al. Calcium channel blockers are associated with lower gastric cancer risk: A territory-wide study with propensity score analysis. Int J Cancer. 2021;148:2148\u201357.","journal-title":"Int J Cancer"},{"key":"1887_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/jcph.1579","volume":"60","author":"JH Shih","year":"2020","unstructured":"Shih JH, Kao LT, Chung CH, et al. Protective Association Between Calcium Channel Blocker Use and Breast Cancer Recurrence in Postsurgical Women: A Population-Based Case-Control Study in Taiwan. J Clin Pharmacol. 2020;60:785\u201392.","journal-title":"J Clin Pharmacol"},{"key":"1887_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1159\/000439101","volume":"33","author":"M Kudo","year":"2015","unstructured":"Kudo M, Kitano M, Sakurai T, et al. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015;33:765\u201370.","journal-title":"Dig Dis"},{"key":"1887_CR25","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s00520-015-3062-5","volume":"24","author":"B Arnold","year":"2016","unstructured":"Arnold B, Mitchell SA, Lent L, et al. Linguistic validation of the Spanish version of the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Support Care Cancer. 2016;24:2843\u201351.","journal-title":"Support Care Cancer"},{"key":"1887_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.semcancer.2020.04.006","volume":"68","author":"A Kirtonia","year":"2021","unstructured":"Kirtonia A, Gala K, Fernandes SG, et al. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. Semin Cancer Biol. 2021;68:258\u201378.","journal-title":"Semin Cancer Biol"},{"key":"1887_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.660943","volume":"11","author":"JA Carlos-Escalante","year":"2021","unstructured":"Carlos-Escalante JA, de Jes\u00fas-S\u00e1nchez M, Rivas-Castro A, et al. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Front Oncol. 2021;11: 660943.","journal-title":"Front Oncol"},{"key":"1887_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12094-016-1608-8","volume":"19","author":"SA Kim","year":"2017","unstructured":"Kim SA, Moon H, Roh JL, et al. Postdiagnostic use of \u03b2-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up. Clin Transl Oncol. 2017;19:826\u201333.","journal-title":"Clin Transl Oncol"},{"key":"1887_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijcard.2014.10.028","volume":"179","author":"MC Wong","year":"2015","unstructured":"Wong MC, Tam WW, Lao XQ, et al. The incidence of cancer deaths among hypertensive patients in a large Chinese population: a cohort study. Int J Cardiol. 2015;179:178\u201385.","journal-title":"Int J Cardiol"},{"key":"1887_CR30","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3109\/10428194.2014.901513","volume":"55","author":"YK Chae","year":"2014","unstructured":"Chae YK, Dimou A, Pierce S, et al. The effect of calcium channel blockers on the outcome of acute myeloid leukemia. Leuk Lymphoma. 2014;55:2822\u20139.","journal-title":"Leuk Lymphoma"},{"key":"1887_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0895-7061(96)00219-1","volume":"9","author":"JR Daling","year":"1996","unstructured":"Daling JR. Calcium channel blockers and cancer: is an association biologically plausible? Am J Hypertens. 1996;9:713\u20134.","journal-title":"Am J Hypertens"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-022-01887-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T15:08:28Z","timestamp":1661008108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-022-01887-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1007\/s00535-022-01887-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}